Biological Assembly 1  

 3D View: Structure | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 116340.17 
• Atom Count: 7733 
• Residue Count: 1000 
• Unique protein chains: 2

1REV

HIV-1 REVERSE TRANSCRIPTASE

• DOI: 10.2210/pdb1REV/pdb

• Classification: NUCLEOTIDYLTRANSFERASE
• Organism(s): Human immunodeficiency virus type 1 group M subtype B
• Expression System: Escherichia coli


• Deposited: 1995-09-17 Released: 1996-10-14 
• Deposition Author(s): Ren, J., Esnouf, R., Hopkins, A., Ross, C., Jones, Y., Stammers, D., Stuart, D.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.6 Å
• R-Value Work: 0.224 

Literature

The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design.

Ren, J., Esnouf, R., Hopkins, A., Ross, C., Jones, Y., Stammers, D., Stuart, D.

(1995) Structure 3: 915-926

• PubMed: 8535785 
• DOI: 10.1016/S0969-2126(01)00226-X
• Also Cited By: 1DTT, 1DTQ


• PubMed Abstract: 
  

HIV reverse transcriptase (RT) is a key target of anti-AIDS therapies. Structural studies of HIV-1 RT, unliganded and complexed with different non-nucleoside inhibitors (NNIs), have pointed to a common mode of binding and inactivation through distortion of the polymerase catalytic site by NNIs containing two hinged rings. The mode of binding of the TIBO family of inhibitors is of interest because these compounds do not fit the two-hinged-ring model.

---

Related Citations: 

• Crystals of HIV-1 Reverse Transcriptase Diffracting to 2.2 A Resolution
  Stammers, D.K.,Somers, D.O.,Ross, C.K.,Kirby, I.,Ray, P.H.,Wilson, J.E.,Norman, M.,Ren, J.S.,Esnouf, R.M.,Garman, E.F.
  (1994) J.Mol.Biol. 242: 586
• Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Non-Nucleoside Inhibitors
  Esnouf, R.,Ren, J.,Ross, C.,Jones, Y.,Stammers, D.,Stuart, D.
  (1995) Nat.Struct.Mol.Biol. 2: 303
• High Resolution Structures of HIV-1 RT from Four RT-Inhibitor Complexes
  Ren, J.,Esnouf, R.,Garman, E.,Somers, D.,Ross, C.,Kirby, I.,Keeling, J.,Darby, G.,Jones, Y.,Stuart, D.,al., et
  (1995) Nat.Struct.Mol.Biol. 2: 293




---

Organizational Affiliation: 

Laboratory of Molecular Biophysics, Oxford, UK.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
HIV-1 REVERSE TRANSCRIPTASE	A	560	Human immunodeficiency virus type 1 group M subtype B	Mutation(s): 0  Gene Names: gag-pol
Find proteins for P04585 (Human immunodeficiency virus type 1 group M subtype B) Go to UniProtKB:  P04585

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details
HIV-1 REVERSE TRANSCRIPTASE	B	440	Human immunodeficiency virus type 1 group M subtype B	Mutation(s): 0  Gene Names: gag-pol
Find proteins for P04585 (Human immunodeficiency virus type 1 group M subtype B) Go to UniProtKB:  P04585

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
TB9	A	4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE C16 H20 Cl N3 S RCSLUNOLLUVOOG-NSHDSACASA-N
MG	A	MAGNESIUM ION Mg JLVVSXFLKOJNIY-UHFFFAOYSA-N

Modified Residues  1 Unique
ID	Chains	Type	Formula	2D Diagram	Parent
CSD	A	L-PEPTIDE LINKING	C3 H7 N O4 S		CYS

External Ligand Annotations
ID	Binding Affinity (Sequence Identity %)
TB9	IC50: 0 nM (99) BINDINGDB
TB9	EC50: 33 - 5600 nM (99) BINDINGDB
TRB	Ki: 33 nM PDBBIND

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.6 Å
• R-Value Work: 0.224 
• Space Group: P 2₁ 2₁ 2₁

Unit Cell:

Length (Å)	Angle (°)
a = 138.800	α = 90.00
b = 115.800	β = 90.00
c = 66.200	γ = 90.00

Software Package:

Software Name	Purpose
DENZO	data reduction
X-PLOR	refinement
X-PLOR	phasing
X-PLOR	model building

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 1995-09-17 
• Released Date: 1996-10-14 
• Deposition Author(s): Ren, J., Esnouf, R., Hopkins, A., Ross, C., Jones, Y., Stammers, D., Stuart, D.

Revision History 

• Version 1.0: 1996-10-14
  Type: Initial release
• Version 1.1: 2008-03-24
  Type: Version format compliance
• Version 1.2: 2011-07-13
  Type: Version format compliance